Quantifying the value of investment in innovation for clinical development

Written By Johnathan Lowery

Hint: The number of days you can shave off a timeline does not automatically translate into downstream revenue.

Coming Soon

Johnathan Lowery
Previous

Why Galthera Research was founded - the mission and vision
Next

Why we don’t (not really) think properly about risk in drug development